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A novel non-mineral oil-based adjuvant. 
I. Efficacy of a synthetic 
sulfolipopolysaccharide in a 
squalane-in-water emulsion in 
laboratory animals 
L A Th Hdgers *°~, P L I Platenburg t, A Lultjens ~, B Groenveld *,
T Dazelle*, M Ferrarl-Laloux* and M W Weststrate * 
Sulfohpopolysacchartdes ( SLPs) were syntheslzed by reaction of the synthetzc polysucrose 
polymer Flcoll-400 with chlorosulfomc acid and lauroyl chloride m anhydrous medlum 
Hydrophoblc derivatives were obtamed by addmon of a small number of  sulfate and a 
large number of  hpzd 9roups Gel-permeation high-performance liquid chromatography 
(9 P -h p l c ) exhibited a wide range m molecular weight of both Flcoll-400 and SLP 
polymers The calculated weight-average molecular weight (Mw) of Flcoll-400 and SLP 
using polystyrene polymers as references was 187000 and 380 000 respectively, exhtbmno 
a twofold mcrease in molecular weight upon derwattzatlon Adjuvantzclty ofhydrophoblc 
SLPs with 0 2 sulfate and 1 5 hpzd 9roups per sucrose monomer, a squalane-m-water 
emulsion (S/W),  SLP incorporated mto S~ W (SLP/S /W) ,  and a mineral od-based 
emulsion (0 /W)  was investigated In combmatlon with different antigens tn mice and 
9ulnea-plgs Antibody responses m serum against ovalbumm (OVA), dmttrophenylated 
bovine serum albumin (DNP-BSA),  reactivated mfluenza wrus strain MRC-11 
( MRC-11), a mixture of three influenza virus strams (iFlu3 ) and mactwated pseudorables 
virus (IPRV) were measured by either haemaggluttnatton (HA), haemagglutmatton 
inhibition (HI) or serum neutrahzatton (SN) Vaccines were prepared by simply mixing 
one volume of antigen wlth one volume of adjuvant solution Antibody tttres after one or 
two mjectlons with these antigens were enhanced stgmficantly by SLP/S /W,  SLP, S~ W 
and O~ W and in most studies, SLP /S /W was demonstrated to be more effective than 
either the two consutuent components or the O / W adjuvant A hydrophlhc SLP-dertvatlve 
with a high sulfate/hpM ratio Incorporated into S~ W appeared to be meffecttve, which 
indicates the Importance of a hydrophobtc character of SLP Apphcabdtty of SLP /S /W 
as a novel non-mineral od-based adjuvant is discussed 
Keywords Adjuvant, sulfollpopolysacchande, on-mineral od, squalane-ln-water emulsion, synthetic polymer, 
lmmunostlmulatlon 
It is well recogmzed that a novel generation of vaccines 
based on well defined pure antigens (polypeptides, 
proteins, poly/ollgosacchandes etc) greatly depends on 
progress in the field of antigen presentation and immune 
stimulation In this respect, adjuvants play an important 
role as they are capable of stimulating different ypes of 
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immune responses and, within hmlts, of directing the 
type of response Many compounds with adjuvant 
activity are at present known (for review see Refs 1 to 4) 
but only a few are applied routinely in human and 
veterinary vaccines Alumlmum and calcium salts are the 
only adjuvants hcensed for human use and are also 
applied in vaccines for companion animals Emulsions 
of mineral oil are often the adjuvant of choice for farm 
and laboratory animals since they evoke high immune 
responses These adjuvants, especially those of the 
water-in-oil type, can however provoke undesirable 
side-effects and therefore numerous attempts to develop 
strong and safe adjuvants have been undertaken The 
apphcatlon of the novel adjuvants known at present 
might be hmlted for several reasons, such as disappointing 
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efficacy in the target animal species, insufficient safety, 
problems with large-scale preparation, hmlted stablhty 
of the final formulation etc 
Several years ago, we started a research programme 
on adjuvants without mineral oll for veterinary purposes 
After primary screening of experimental djuvants with 
distinct antigens in laboratory animals, promising 
formulations were tested with appropriate antigens in 
target animal species The adjuvantlclty of one of the 
most interesting preparations ~s presented here This 
novel formulation comprises a derlvatlzed synthetic 
polysucrose which has been demonstrated to contain 
considerable adjuvantlcaty towards a particular antigen 
and a protein in mice 5 Acuvity of these so-called 
sulfohpopolysaccharldes (SLPs) towards viral antigens 
was disappointing and therefore we attempted to 
improve efficacy by the use of physical vehicles SLPs 
were incorporated into different types of vehicles and 
adjuvantlclty of a hydrophoblc SLP in an emulsion of 
squalane-ln-water was examined in laboratory animals 
MATERIALS  AND METHODS 
Animals 
Random outbred Swiss 10-12-week-old female mice 
(Harlan, Zelst, The Netherlands) with a minimum weight 
of 15 g and female 10 12-week-old guinea-pigs (Harlan) 
with a minimum weight of 200 g were used 
Antigens 
Dinltrophenylated bovine serum albumin (DNP-BSA, 
22 DNP groups per BSA molecule) was prepared as 
described previously 6 Influenza virus strains MRC-II  
(MRC-11), A/Swine (A/Swine) and X-79 (X-79) were 
grown in embryonated eggs, purified by centrlfugatlon 
on a sucrose gradient and inactivated by Incubation with 
0 05% ~-proplolactone plus 0 01% thlmerosal for 4 days 
at 4~C and subsequently for 3 days at room temperature 
Pseudorables virus (1PRV, Bartha strain) was grown on 
PDs-cell cultures and inactivated by adding glutar- 
aldehyde at a final concentration of0 2% and subsequent 
Incubation for 2 h at 37°C The following doses of antigen 
were injected in animals l0/~g ovalbumln (OVA), 10/~g 
DNP-BSA, 1 #g MRC-11, a mixture of three influenza 
virus strains (1Flu3) comprising 044 #g A/Swine + 0 40/lg 
MRC-11 +02 #g X-79, and 104 TCIDso IPRV 
Adjuvants 
SLPs were synthesized as described previously 5 
Briefly, 80g polysucrose, Mw 400000, (Ficoll-400, 
Pharmacia, Uppsala, Sweden) was dissolved in a mixture 
of 50ml anhydrous pyridlne and 300ml dlmethyl- 
formamxde and this solution was then dried by molecular 
sieves (02 nm, Merck, Darmstadt, Germany) To this 
mixture, 125 ml lauroyl chloride (Merck) was added and 
the mixture was incubated for 6h at 70°C and 
subsequently for 18 h at room temperature Then, 5 ml 
anhydrous chlorosulfonlc acid (Merck) in 20 ml anhydrous 
dlmethylformamlde (DMF) was added and the mixture 
was incubated again for 6 h at 70°C and 18 h at room 
temperature Solvents were evaporated and the syrup was 
neutralized with 1 M NaOH solution, dlalysed extensively 
against water and finally lyophihzed Dried SLP was 
dissolved in ethanol and mixed with 10ml squalane 
(Merck) per gram SLP The ethanol was evaporated 
thoroughly at low pressure and elevated temperature 
The SLP/squalane mixture was added to phosphate- 
buffered saline containing 2% Tween 80 (PBS/Tw80) at 
final concentrations of 1% w/v SLP and 10% v/v 
squalane This mixture was emulsified by mlcrofluldlZatlon 
(Mlcrofluldlzer model M 110 Y, Mlcrofluldics Corp, 
Newton, MA, USA) at a working pressure of about 10 000 
psi (pounds per square inch) or by ultrasonic vibration 
(Branson Sonlfier Power Company, Danbury, UK) The 
emulsification procedure was continued until no droplets 
with a diameter of >2-3  #m were visible under the 
microscope at 1000-fold magnification Squalane-ln- 
water without SLP (S/W) was prepared as described for 
SLP/S/W SLP adjuvant solution was prepared by 
suspending SLP in PBS/Tw80 by mlcroflmdIzlng or 
ultrasonic vibration The mineral oil-in-water emulsion 
(O/W) tested is the adjuvant applied in various 
commercial vaccines of Solvay Duphar BV (Weesp, The 
Netherlands) and comprised 50% mineral oil, 5% of a 
hydrophlhc (Tween 80) and 5% of hpophlhc detergent 
(Arlacel A) to stablhze the emulsion 
Chemical analysis of SLP 
Chemical composition of SLP was determined by gross 
chemical analysis as described previously 5 Briefly, sugar 
content was measured by the method of Dubols et al ~ 
SLP solublllzed in DMF was hydrolysed by adding HC1 
at a final concentration of 4 M and incubating for 6 h at 
100~C Sulfate and hpld contents in the mixture were 
determined according to the procedure described by 
Dodgson and Price 8 and Duncombe 9, respectively The 
amount of free hpld was determined before hydrolysis 
and the total amount of hpld was determined after 
hydrolysis The quantity of bound lipid was calculated 
by subtraction of the free hpld content from the total 
lipid content 
Determination of the molecular weight of Ficoli-400 and 
SLP 
The molecular weight of Flcoll-400 and SLP was 
determined by gel-permeation high-performance liquid 
chromatography (g p -h p 1 c ) using a TSKgel G5000 HXL 
column (TosoHaas, Montgomeryvllle, PA), and DMF 
with 0 05 M LIBr as eluent Samples of polystyrene with 
weight-average molecular weight (Mw) between 10000 
and 1000000 (TosoHaas) were used as standards 
Samples of SLP or Flcoll-400 in DMF were applied to 
the column and the retention time of the compounds was 
determined by refractive index detection M w values of 
SLP and Flcoll-400 were calculated using the polystyrene 
standards 
CharacterlzaUon of the SLP/S/W emulsions 
The emulsion of SLP/S/W was characterized by 
determination of the particle-size distribution of the oil 
droplets by laser diffraction using a mlcropartlcle slzer 
(Malvern Masterslzer Model $2 02, Malvern Instruments 
Ltd, Worcs, UK) and PBS/Tw80 as diluent 
Vaccines and vaccination 
Vaccines were prepared by mixing one volume of 
antigen solution with one volume of adjuvant solution 
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Groups of five animals were injected subcutaneously (s c ) 
with 0 2 ml vaccine per animal, unless stated otherwise 
Mice were injected once at week 0 and blood was 
collected at week 3 Guinea-pigs were immunized twice, 
at week 0 and week 3, and blood samples were collected 
3 weeks after the second injection (week 6) 
Antibody titres against DNP and OVA 
Antl-DNP and anti-OVA antibody titres were measured 
by a haemagglutlnatlon (HA) reaction using DNP-  or 
OVA-derlvatlzed sheep red blood cells (DNP-SRBC and 
OVA-SRBC, respectively) as indicator cells a° Briefly, 
serum samples were serially diluted twofold in saline 
containing 1% normal rabbit serum in round-bottomed 
96-well plates, suspensions of 025% DNP-SRBC or 
OVA-SRBC in saline were added and plates were 
incubated at room temperature The reciprocal serum 
dilution which just gave agglutination was considered to 
be the tltre 
Antibody titres against influenza virus 
Anti-influenza virus antibody tltres were measured by 
a haemagglutlnatlon i hibition test (HI) Sera were 
Inactivated at 56°C for 30 mln and treated with 25% 
kaolin (Ref 11, ICN/F low Laboratories, Irvine, UK) by 
mixing four volumes of kaolin with one volume of serum 
and subsequent incubation of the mixture for 30 mln at 
room temperature The kaolin was spun down and 
supernatants were collected and serially diluted in 
veronal-buffered saline (pH 7 2, 0 025 M) containing 0 1% 
BSA (VBS/BSA) in round-bottomed 96-well plates Four 
HA units ot the appropriate strain of influenza virus were 
added to each well and the plates were incubated for 1 h 
at room temperature Washed chicken red blood cells at 
a concentration of 0 25% in VBS/BSA were added and 
after a time period of 0 5-2 h depending on the virus 
strain tested, agglutination was detected The highest 
reciprocal serum dilution demonstrating HI was considered 
to be the tltre 
Antibody titres against PRV by serum neutralization 
(SN) 
Serum samples of individual animals were inactivated 
by incubating for 30 min at 55°C Next, 50 ~l of the serum 
samples were diluted twofold in culture medium in 
95-well mlcrotitre plates and subsequently 50 #l of a virus 
suspension containing 100 TCID5o of PRV were added 
After incubation for 24h at 37°C, 50#1 of a cell 
suspension containing 2 × l0 a PD 5 cells were added to 
the wells Plates were incubated for 5 days at 37°C and 
the cytopathogenic effect in the different wells was scored 
The reciprocal value of the serum dilutions resulting in 
50% neutralization of the virus was considered as 
antibody titre 
Statistical analysis 
Serum samples were always tested in duphcate and 
mean values were calculated provided that the difference 
between the two individual values was not more than 
one 2-log unit (one twofold dilution step) In each assay, 
negative and positive standard serum samples were 
included and the test was considered valid if the deviation 
of the mean value of these standards did not exceed one 
2-log unit (one dilution step) Results are expressed as 
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the arithmetic mean of n independent observations_+ 
standard error of the mean (s e m)  Factor of increase 
(FOI) was determined by calculation of the antilog value 
of the difference between geometric means of the 
experimental group immunized with antigen plus adjuvant 
and the control group immunized with antigen alone 
Student's t test was performed to analyse the statistical 
significance of the results Values of p>005 were 
considered not to be significant 
RESULTS 
Molecular weight of SLP 
SLPs were synthesized using as backbone Ficoll-400, 
which is a synthetic opolymer of eplchlorohydrln and 
sucrose 12 The precise eplchlorohydrin/sucrose ratio is 
not known but the highly branched structure implicates 
a value > 1 0 The molecular weights of Ficoll-400 and 
SLP were determined by g p -h p 1 c using polystyrene as 
reference DMF was employed as eluent as both SLP 
and Ficoll-400 are soluble in this solvent Analysis of 
polystyrene polymers of differing Mw revealed significant 
hnearity in the range 10000-1000000 (Ftgurel) Flcoi1- 
400 exhibited a wide range of polymers with molecular 
weights from < 10 000-1000 00 SLP gave a comparable 
pattern although a considerable polymer fraction displayed 
molecular weights > 1000 000 The calculated molecular 
weights of Ficoll-400 and SLP were 187 000 and 380 000, 
respectively 
Chemical composition of SLP 
Various laboratory batches of SLP wlth low sulfate 
and high lipid contents were synthesized and chemical 
composition of the SLPs was estabhshed by determination 
of sugar, sulfate and lipid contents before and after 
complete hydrolysis (Table 1) The sugar content of SLP 
was about 50% w/w Before hydrolysis, a significant 
amount of laurie acid but no sulfate was detected After 
hydrolysis with 4 M HC1, a considerable quantity of 
sulfate and a high quantity of lipid were detected From 
the difference in sulfate and lipid content before and after 
hydrolysis, the number of groups per sucrose monomer 
linked covalently was calculated, taking the molecular 
weight of the sucrose monomer of Ficoll-400 to be 
400 The sulfate ratio was 024_+008 and the lipid 
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Flgure 1 G p-h p lc patterns of Fmoll-400 and SLP analysed on a 
TSKgel G5000 HxL h p I c column Polystyrene polymers with MWs 
ranging from 10000 to 1000000 (rT) were used as reference 
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Table 1 Chemical composttton of SLP 
Difference between 
before and after 
Content Content hydrolysis 
before after 
hydrolysis" hydrolysB Content 
Component (mg g 1) (mg g - l )  (mg g 1) Ratio b 
Sugar 510 (24) NT - - 
Sulfate <5 43 (14) 43 (14) 0 24 (0 08) 
L~p~d 64 (39) 450 (140) 386 (121) 1 5 (0 6) 
Values are given as mean (standard dewabon) 
aSugar, sulfate and hpld contents of three laboratory batches of SLP 
were determmed before and after treatment with 4 M HCI for 6 h at 100 C 
Ficoll-400, launc acid and Na2SO4 were used as standards 
bRabo expressing the number of sulfate or hpid groups per sucrose umt 
was calculated assuming that one sucrose monomer of Fico11-400 B 
400 
ratio was 1 5+0 6 On the basis of these results and 
data on chemical composition of Flcoll-400 described 
elsewhere, the structure of the SLP monomer was 
established and is represented in Figure 2 
SLPs with low sulfate/lipid ratm were poorly soluble 
in water and readily soluble m organic solvents, e g 
ethanol, chloroform and dlchloromethane 
and SLP/S/W 32- to 48-fold increase in antibody titre 
against he DNP hapten 
Enhancement of antibody responses to inacnvated 
viruses in mice 
The effect of SLP/S/W, SLP and S/W on the humoral 
response against MRC-11 was examined in mice Three 
weeks after a single injection of antigen without adjuvant 
low t]tres of antibodies against MRC-I  1 were observed 
(Table 3) SLP, S/W and SLP/S/W induced significant 
mcreases in antibody tltre and tltres evoked by SLP/S/W 
were significantly higher than those obtained by the 
individual components 
The Influence of SLP/S/W on viral antigens was 
further Investigated using an Inactivated porcine herpes 
virus, 1PRV Groups of mice were injected with IPRV 
with or without adjuvant and antibody titres in serum 
were measured by virus neutralization (Table 3) Addition 
of S/W did not result in augmented responses while 
application of either SLP or SLP/S/W gave significant 
six- to 14-fold increases 
Microparticle-size distribution of SLP/S/W 
The distribution of particle diameters of various 
SLP/S/W emulsions was determined and an example of 
the plot of frequency versus diameter is demonstrated 
(Ftgure 3) More than 98% of the particles were < 1 pm 
and 99 9% <2 #m Different SLP/S/W emulsions can 
be compared by expression of the maximum diameter 
(MD) of the 10%, 50% and 90% portion of the 
smallest particles and for five different laboratory 
batches of SLP/S/W emulsions the following mean 
values (_+ s e m)  were obtained MD(10%), 0 18_+0 02, 
MD(50%), 0 34 _+ 0 08, and MD(90%), 0 91 _ 0 60 pm 
One batch of SLP/S/W was incubated for more than 
7 months at 4~C and particle-size distribution was 
analysed Separation of phases could not be detected and 
MD(10%) remained 0 18 pm The values of MD(50%) 
and MD(90%), however, increased from 0 30 to 0 36 and 
from 059 to 1 97 #m, respectively The fraction of 
particles with a diameter of < 1 0/~m decreased from 96 
to 85% 
Effect of SLP/S/W on humeral response to a protein 
and hapten carrier in mice 
Groups of mice were injected once with OVA and 
antibody titres in serum were measured 3 weeks later 
OVA without adjuvant induced considerable levels of 
antibodies (Table 2) Neither SLP nor S/W enhanced 
the response whereas SLP/S/W provoked in both 
independent experiments an increase in antibody tltres 
by a factor of 5 to 10 
In two separate xperiments, the effect of SLP/S/W, 
S/W, SLP and O/W on the antibody response to hapten 
conjugated to a protein was investigated in mice Low 
but detectable levels of antibody tltres were observed 
after a single injection of antigen without adjuvant (Table 
2) O/W and S/W emulsions did not enhance the 
responses whereas SLP alone and SLP/S/W induced 
significant increases of titres SLP alone gave a 16-fold 
CH2OR 
~ -~  O. ROCH 2 / O _ _  ½ 
RO ~ ~ C H 2 0 R  
OR 
(q) 
R = ratio 
R 2 = -SO3H or-SOsNa 0 24 
R 3 =-CO-(CHz) Io -CH 3 I 6 
R 4 =-H < 5 16 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
R 5 = R 2 or R 3 or R 4 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
ratto B the number of groups per sucrose-monomer 
n is about 500 
Ftgure 2 Chemica l  s t ruc ture  of the sucrose  monomer  of SLP 
(¢ 
cJ 
100 
80 
6O 
20 
0 
O1 OA 
f 
/ 
/ 
/ 
5 1 2 3 10 20 50 I OU 
)a I [ l¢ ]C  blT( ~ID In lL IOn%)  
2 
<1. 
Figure 3 Distnbubon of the s~ze of droplets of a SLP/S/W emulsion 
Bars indicate the relattve frequency of particles with a given diameter 
and the hne represents the cumulattve values (%) 
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Table 2 Effect of SLP/S/W, S/W and SLP on antibody tttres against two protein model anttgens in mtce 
2-log anhbody tttre 3 weeks after ~mmumzatton 
Experiment 1 Experiment 2 
Group Adjuvant Mean s e m FOI S Mean s e m FOI S 
Anti-OVA 
1 - 64 18 - a 66 09 - a 
2 SLP/S/W 9 7 3 2 10 b 9 0 2 5 5 b 
3 S/W 88 1 9 5 a 68 1 3 1 a 
4 SLP 74 1 3 2 a 58 04 <1 a 
Antt-DNP 
1 - 34  15 - a 40 08 - a 
2 SLP/S/W 9 0 1 7 49 b 9 0 2 0 32 b 
3 O/W NT - 4 8 1 8 2 a 
4 S/W 2 2 1 6 < 1 a NT - 
5 SLP 7 4 0 9 16 b NT - 
NT, not tested 
Groups of five animals were immuntzed subcutaneously with either OVA or DNP-BSA and anttbody tttres agamst OVA and DNP were measured 3 
weeks later by HA Mean value, s e m, factor of increase (FOI) and statlshcal slgmhcance (S) are represented Groups that are not stattsttcally different 
(p >0 05) are indicated by the same letter 
Table 3 Effect of SLP/S/W, S/W and SLP on antibody responses against two machvated viruses m mtce 
2-log antibody t~tre against 
MRC-11 IPRV 
Group Adjuvant n Mean s e m FOI S n Mean s e m FOI S 
1 - 15 14 15 - a 5 14 15 - a 
2 SLP/S/W 15 9 0 1 4 194 b 5 5 2 1 5 14 b 
3 S/W 15 6 5 1 5 34 c 5 1 8 1 3 1 a 
4 SLP 10 5 8 1 2 21 c 5 4 0 2 3 6 b 
Groups of five mtce were immuntzed wtth macttvated influenza vtrus MRC-11 or ~PRV m combination wtth the adluvants indicated Three weeks after 
Jmmumzatron, antibody titres against MRC-11 or iPRV were measured by HI and SN, respectively Results of three mdependent expertments on 
MRC-11 were taken together Total number of ammals tested (n), mean value, se  m, factor of increase (FOI) and stattshcal slgmficance (S) are 
represented Groups that are not statlshcally different (p>0 05) are indicated by the same letter 
Effect of SLP/S/W on antibody responses against 
influenza virus in guinea-pigs 
Adjuvantlc l ty of SLP /S /W was compared with that of 
O /W in guinea-pigs This animal species was selected as 
i t  IS often used fo r  potency  tests o f  commerc ia l  p roducts  Group Adluvant n Mean s e m FOI S 
In five independent experiments, groups of five or ten 
animals were immunized twice with a mixture of three Anh-A/Swme 
1 - 25 55 2 0 - a 
Influenza virus stratus (iFlu3) with or without adjuvant 2 SLP/S/W 25 9 7 1 5 18 19 
and ant ibody tltres were measured 3 weeks after the 3 o/w 30 89 1 3 11 c 
second vaccinat ion (Figure 4) Antigen without adjuvant Anh-MRC-11 
evoked moderate tltres agamst he three different viruses 1 - 25 6 7 1 0 - a 
and both  SLP /S /W and O/W increased  the  ant ibody  2 SLP/S/W 25 9 7 0 9 8 b 
levels Mean factors of increase (FOI)  in immune 3 o/w 30 95 1 4 7 b 
responses against A/Swine, MRC-11 and X-79 were 26, A n t t - X - 7 9  
9 and 6 for SLP /S /W and 9, 6 and 3 for O /W,  respectively 1 - 25 6 6 0 9 - a 
(Table 4) If results of the five experiments were taken 2 SLP/S/W 25 9 4 0 6 7 b 
3 O/W 30 8 4 0 8 3 c together, SLP /S /W was more effective than O/W in 
st imulat ing humera l  responses against A/Swine and X-79 AntHPRV 
1 - 25 63 1 5 - a 
but  not  aga ins t  MRC- I  1 s t ra in  2 SLP/S/W 25 12 0 2 4 52 b 
3 O/W 10 7 0 1 5 2 a 
4 S/W 15 9 6 2 1 10 c 
Augmentation of humeral immune responses against 
iPRV by SLP/S/W, S/W and O/W in guinea-pigs 
Adjuvantic i ty of SLP /S /W for responses against IPRV 
was compared with that of either S /W and O/W (Ftgure 
5) SLP /S /W and S /W but not O /W significantly 
enhanced the humera l  response in guinea-pigs measured 
3 weeks after the second vaccination S /W without SLP 
Table 4 Comparison of the effects of SLP/S/W, S/W and O/W on 
anttbody responses against reactivated influenza and pseudorabies vtrus 
in gumea-ptgs 
2-log ant=body tttre at week 6 
Results of the five independent expertments of Figures 4 and 5 were 
taken together Gumea-plgs were tmmumzed intramuscularly with etther 
iFlu3 or tPRV plus dtfferent adjuvants at weeks 0 and 3 and antibody 
tttres agamst iFlu3 and IPRV were measured at week 6 by HI and SN, 
respechvely Total number of animals (n), mean value, s e m, factor of 
fncrease (FOI) and stattsttcal slgmftcance (S) of the results are 
represented Groups whtch are not statmtlcally different (p>0 05) are 
indicated by the same letter 
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was less effective than SLP/S/W and mean factors of 
increase were 10 and 52, respectively (Table 4) 
Adjuvanticlty of hydrophobic and hydrophflic SLP 
derivatives 
The effects of a hydrophoblc and two hydrophlhc SLPs 
in combination with a squalane-in-water emulsion were 
tested with either OVA in mice or 1PRV in guinea-pigs 
The sulfate/hpld ratio of the hydrophoblc SLP was 
0 1/08 while the hydrophlhc SLP tested m mice 
and gmnea-pigs gave values of 06/001 and 16/08, 
respectively 
In mice, antibody responses against OVA were 
stimulated by the hydrophoblc but not the hydrophdlc 
SLP in squalane-ln-water (Table 5) In guinea-pigs, the 
hydrophdlc SLP formulated in S/W induced a slight, 
is i insignificant enhancement of antibody levels against 
=~ t a 1PRV while the hydrophoblc derivative gave a high, 
,~ 256-fold increase 
~ D ISCUSSION 
~' The incidence, morbidity and mortahty of a large number 
of infectious diseases in humans and animals have been 
diminished by vaccination Both live and inactivated 
antigens are used for this purpose Inactivated vaccines 
usually require supplementation with adjuvants for 
m nt E E 3 'e E 5 sufficient efficacy but addition of such compounds i  often 
accompanied by increased toxicity The ideal adjuvant is 
considered to be a product which stimulates adequate 
~2 immunity against he appropriate antigen(s) or epltope(s) 
of a pathogen without generating detrimental side-effects 
It exerts long-lasting stabdlty, is easy to handle and is 
effective in combination with different pathogens and in 
l o F [ -~ different animal speoes It is well recogmzed that the 
o / I I adjuvants at present available do not meet all these 
criteria and compromises are made between efficacy, 
toxicity, performance etc In this paper, the adjuvantlclty 
of a combination of SLP and squalane-ln-water for 
E E F 
O,  0 ' 
Experiment 1 Experiment 2 Experiment Experiment 4 Experiment Experiment 1 Experiment 2 Experiment 3 Experiment 4 Experiment 
Figure 4 Effect of various adJuvants on the anbbody response against Figure 5 Effect of various adJuvants on the antibody response against 
influenza virus (a) A/Swine, (b) MRC-11 and (c) X-79 in guinea-pigs after IPRV in guinea-pigs after two veccmatlons Mean values of five animals 
two vaccinations Mean values of five animals are represented and are represented and vertical bars indicate s e m i ,  no adjuvant, [ ]  
vertical bars indicate s e m I I ,  no adJuvant, r ] ,  SLP/S/W, C1, O/W SLP/S/W, UI, O/W, Ira, S/W 
Table S Adjuvanbctty of hydrophobtc and hydrophdm SLPs incorporated in S/W m m~ce and guinea-pigs 
2-log antibody tltre against 
OVA m m~ce IPRV in guinea-pigs 
Group Adjuvant S/L ratio n Mean s e m FOI S n Mean s e m FOI S 
1 - 10 65 14 - a 5 51 20 - a 
2 SLP/S/W 0 1/0 8 10 9 4 2 4 7 b 5 13 1 2 5 256 b 
3 SLP/S/W 0 6/0 01 10 5 9 0 9 < 1 a NT - 
4 SLP/S/W 1 6/0 8 NT 5 7 7 2 3 6 a 
S/L ratio, sulfate/lipid ratio, NT, not tested 
Groups of n animals were immunized with the anbgen indicated plus different SLP/S/W formulations Antibody responses against OVA in m~ce were 
measured 3 weeks after the first rejection by HA whereas antibody tltres against ~PRV m guinea-pigs were determined 3 weeks after the second 
injection by SN Mean values, s e m, factor of increase (FOI) and statlsbcal significance (S) are represented Groups that are not statistically different 
(p > 0 05) are indicated by the same letter 
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humoral response against various types of thymus- 
dependent antigens was investigated in two species of 
laboratory animals, mice and guinea-pigs 
Originally, SLPs were synthesized to mimic the 
synergistic adjuvant activity of combinations of a sulfated 
polysaccharide, I e dextran sulfate, and surface-active 
agents, e g dimethyldloctadecylammonlum bro ide, 
non-Ionic block polymers of polyoxyethylene plus 
polyoxypropylene 13'14 The polysucrose backbone of 
SLP is Flco11-400, a synthetic opolymer of sucrose and 
eplchlorohydrin with a highly branched, approximately 
spherical structure 12 Properties of the polymeric SLP 
were determined by chemical characterization f the 
monomer and establishment of the molecular weight 
distribution The chemical composition of the SLP 
derivatives investigated was determined by gross analysis 
which included the assessment of sugar, sulfate and hpld 
content before and after acid hydrolysis Differences 
between lipid content before and after this treatment 
revealed that 1>85% of the lipid present was coupled 
covalently to the polysucrose backbone Sulfate could 
only be detected after hydrolysis, indicating that sulfate 
was completely inked covalently The mean numbers of 
sulfate and hpld groups per sucrose monomer of the 
hydrophobIc SLP batches investigated were 0 24 and 1 5, 
respectively On the basis of these data plus information 
on Ficoll-400 obtained from the supplier a2, the chemical 
composition of the sucrose derivative as a monomer of 
SLP could be deduced (Figure 2) Additional analysis 
largely confirmed this chemical composition (Hllgers et 
al, manuscript in preparation) 
Analysis of Flcoll-400 and SLP by g p -h p 1 c exhibited 
a wide range of molecular weights between < 10 000 and 
> 1000000 This polydlsperse profile of F1co11-400 has 
been described previously by others using Sephadex 
G-200 for gel-permeation chromatography is The values 
for M w of Flcoll-400 and SLP calculated using 
polystyrene standards were 187000 and 380000, 
respectively, which is in accordance with the increase 
expected on the basis of the number of sulfate 
and lipid groups added The Mw of Flcoll-400 found is 
less than the value of 400 000 indicated by the producer 
as measured by light scattering, which might be due to 
differences in the test system Analysis by classical 
gel-permeation column chromatography and sedimenta- 
tion also presented significantly lower Mw values for 
Flcoll-400 than the 400000 suggested 15 From the data 
presented, it was concluded that the polymeric structure 
of Flcoll-400 is preserved uring the synthesis procedure 
of SLP, Mw increased twofold upon derlvatization as 
expected, and SLP is a collection of polymers with a wide 
range of molecular weights and a M w of about 380 000 
Because of the presence of both hydrophoblc and 
hydrophlllc moieties, SLP is considered to be a 
surface-active agent The hydrophobic character of SLP 
is brought about by the aliphatic hains (lauroyl groups) 
while the sulfonate and hydroxyl groups establish the 
hydrophlhc character The ratio between sulfate and hpld 
groups determines the hydrophlllc-llpophlllc balance 
(HLB), which is low for the adJuvant-active SLPs on the 
basis of solubihty in aqueous and organic solvents 
Although many SLP derivatives displayed considerable 
adjuvantlcIty depending on sulfate and lipid content and 
length of the lipid chain, activity was insufficient for 
application i  veterinary vaccines Several posslblhtles to 
improve activity was considered and examples of 
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increasing adjuvanticlty of surface-active agents by the 
use of a physical support have been described in the 
literature Non-ionic block polymers of polyoxyethylene 
and polyoxypropylene 16, and monophosphollpld A-
derivative plus trehalose dImycolate x7incorporated into 
an emulsion of squalane-in-water d monstrated nhanced 
activity 
Hydrophoblc SLPs incorporated into a squalane- 
in-water emulsion (SLP/S/W) displayed significant 
adjuvantlclty for the antibody responses to various types 
of antigens in both mice and guinea-pigs Within limits, 
the ratio of sulfate to hpids in SLP could vary without 
significant effect on adjuvantlclty in combination with 
S/W Both constituent components S/W and SLP 
possessed adjuvantxclty but S/W was ineffective in 
combination with OVA, DNP-BSA and 1PRV while SLP 
failed to increase antibody titres against OVA The 
combination of these two compounds was effective 
towards all antigens tested and an overall higher activity 
was observed Both additional nd synergistic Interaction 
between the two components could be detected 
Comparison of SLP/S/W with O/W revealed that 
the experimental djuvant was more effective than the 
commercially supplied one with the exception of the 
response against he Influenza virus strain MRC-11 in 
guinea-pigs The hydrophoblc haracter of the SLP 
seemed to be Important as hydrophllic derivatives (with 
relatively high sulfate/lipid ratios) in combination with 
S/W were not effective 
Differences in antibody responses between independent 
experiments could be observed (Fzgures 4 and 5) 
Constant results with standard serum samples included 
in each test and simultaneous testing of serum samples 
from distinct experiments (data not shown) rule out the 
possibility that variation was introduced uring serum 
analysis Differences in antibody responses to antigen 
without adjuvant, however, suggest that variation in 
either immunogenlcity of antigen preparation orimmuno- 
responsiveness of the animal rather than differences 
in SLP/S/W-batches contributed to lnterexperimental 
variation 
In the literature, several other hydrophobIc surfactants 
with apparent adjuvant activity have been described, eg 
hpophIllc amines i , polyoxyethylene- polyoxypropylene 
copolymers 19, lipid A derivatives 2°, hpophihc muramyl- 
dlpeptlde 21, tripalmltoyl peptade 22 and trehalose dl- 
mycolate 23 SLP distinguishes itself from these surface- 
active adjuvants as it is of much higher molecular weight 
(Mw of 380 000 versus < 10 000) In combination with an 
oil-m-water emulsion, these hydrophoblc surfactants are 
assumed to reside on the interface between oil and water 
where they are capable of binding proteins or other 
substancesl5 19 23 Adsorption of antigens or components 
of the host immune system to the surfactants on the 011 
surface has been considered to be important o the 
adjuvant activity Accumulation of SLP on the surface 
of squalane droplets and subsequent binding of antigen 
or components of the immune system have not been 
established but, together with other possible mode(s) of 
action, are the subject of further esearch 
Stability of an emulsion is an important requirement 
for commercial exploitation In general, the size of the 
011 droplets In an oil-In-water emulsion is indicative of 
stability Emulsions with particles maller than 1 #m are 
considered to be very stable The SLP/S/W prepared on 
a laboratory scale contained very small droplets and 
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more than 90% were smaller than 1 #m Analysis of a 
SLP/S/W batch after incubation at 4°C for more than 
7 months demonstrated a very shght modification of the 
particle-size distribution but no separation of phases 
Another SLP/S/W batch incubated for more than 2 
years at 4°C demonstrated a similar change in particle- 
size distribution (data not shown) Although these results 
suggest that these experimental adjuvant formulations 
are relatively stable emulsions, additional research is 
required to substantiate these data 
In summary, SLP/S /W is a promising non-mineral 
oil-based adjuvant for different types of antigen and is 
at least as effective as the mineral oil adjuvant presently 
used in various veterinary vaccines 
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